Risk Reduction

Staying active and spending less time sitting are highly likely to reduce breast cancer risk, according to researchers.

The initial 90‐day window after ACS represents a vulnerable period for recurrent events, possibly attributable to atherothrombosis mechanisms not currently addressed with optimal therapy, researchers reported.

Compared to current practices of annual screening for hepatitis C virus in men who have sex with men, working toward reducing their risk and screening every 6 months could prove cost effective, according to a presentation.

In this video exclusive, Putting It Into Practice columnist Jonathan D. Leffert, MD, talks with Christie Ballantyne, MD, about cardiometabolic risk reduction and collaboration between cardiology and endocrinology.

Statins used in the general population conferred a 20% risk reduction for colorectal cancer with a possibly larger impact in patients with inflammatory bowel disease, according to an analysis presented during ACG 2020 Virtual.

The CV benefits of BP lowering, for both primary and secondary prevention, were found to be proportional to the intensity of the reduction regardless of baseline BP, researchers reported.

Menopause can be a good time to start addressing CVD risk reduction even though it should be discussed way before then, according to a presentation at the virtual Heart in Diabetes Conference.